OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 127 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $339 | +13.8% | 31,242 | +19.0% | 0.00% | – |
Q1 2024 | $298 | -14.4% | 26,251 | +6.0% | 0.00% | – |
Q4 2023 | $348 | -27.5% | 24,765 | -36.2% | 0.00% | – |
Q3 2023 | $480 | -12.7% | 38,846 | -36.2% | 0.00% | – |
Q2 2023 | $550 | +170.9% | 60,853 | +4.4% | 0.00% | – |
Q1 2023 | $203 | +20.8% | 58,300 | -14.9% | 0.00% | – |
Q4 2022 | $168 | -99.9% | 68,500 | 0.0% | 0.00% | – |
Q3 2022 | $190,000 | -31.9% | 68,500 | 0.0% | 0.00% | – |
Q2 2022 | $279,000 | -7.6% | 68,500 | -3.3% | 0.00% | – |
Q1 2022 | $302,000 | -54.0% | 70,872 | +1.0% | 0.00% | – |
Q4 2021 | $657,000 | +172.6% | 70,172 | +713.8% | 0.00% | – |
Q2 2021 | $241,000 | -13.9% | 8,623 | +2.0% | 0.00% | – |
Q1 2021 | $280,000 | – | 8,450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 2,654,867 | $28,725,661 | 4.46% |
Paradigm Biocapital Advisors LP | 7,903,600 | $85,516,952 | 3.27% |
Logos Global Management LP | 3,208,875 | $34,720,028 | 2.82% |
BVF INC/IL | 9,135,893 | $98,850,362 | 2.77% |
Vivo Capital, LLC | 1,873,704 | $20,273,477 | 1.87% |
Ghost Tree Capital, LLC | 550,000 | $5,951,000 | 1.86% |
GREAT POINT PARTNERS LLC | 796,880 | $8,622,242 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 546,863 | $5,917,058 | 1.40% |
Deep Track Capital, LP | 4,000,000 | $43,280,000 | 1.29% |
HighVista Strategies LLC | 247,880 | $2,682,062 | 0.98% |